Featured Patient Event
What is Graft versus Host Disease or GVHD? Chronic GVHD is a potentially life-threatening condition affecting 40-50% of blood cancer patients who receive an allogeneic stem cell transplant. Join us for an informative discussion as transplant experts explain GVHD risks, how to watch for symptoms, the current treatments available, and new clinical trials aimed at prevention and treatment.
Program Topics:
- What is Graft versus Host Disease and the differences between acute and chronic forms
- The importance of early detection in a potentially life-threatening condition
- Preparing for a stem cell transplant
- Daily life with GVHD and the realities of life with new restrictions
- What GVHD clinical trials are available for both prevention and treatment
- Learn about the LLS Clinical Trial Support Center
